BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21250972)

  • 41. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
    Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
    PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.
    Chen Q; Zheng T; Lan Q; Lerro C; Zhao N; Qin Q; Hu X; Huang H; Liang J; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1332-5. PubMed ID: 23640258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of interleukin-10 promoter single nucleotide polymorphisms and risk of non-Hodgkin lymphoma in a Malaysian population.
    Lim YY; Chin YM; Tai MC; Fani S; Chang KM; Ong TC; Bee PC; Gan GG; Ng CC
    Leuk Lymphoma; 2015 Jan; 56(1):163-8. PubMed ID: 24684230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.
    Shen M; Purdue MP; Kricker A; Lan Q; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Haematologica; 2007 Sep; 92(9):1180-5. PubMed ID: 17666372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic variation in H2AFX contributes to risk of non-Hodgkin lymphoma.
    Novik KL; Spinelli JJ; Macarthur AC; Shumansky K; Sipahimalani P; Leach S; Lai A; Connors JM; Gascoyne RD; Gallagher RP; Brooks-Wilson AR
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1098-106. PubMed ID: 17548670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma.
    Suthandiram S; Gan GG; Mohd Zain S; Bee PC; Lian LH; Chang KM; Ong TC; Mohamed Z
    Tumour Biol; 2015 Mar; 36(3):1819-34. PubMed ID: 25384508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
    Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
    Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C677T and A1298C polymorphisms of methylene tetrahydrofolate reductase in non-Hodgkin lymphoma: southeast Iran.
    Mashhadi MA; Miri-Moghaddam E; Arbabi N; Bazi A; Heidari Z; Sepehri Z; Karimkoshte A; Rezvan A; Hashemi SM
    Tumori; 2018 Aug; 104(4):280-284. PubMed ID: 28430351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
    Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
    Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: a systematic review and pooled analysis.
    Lin HY; Shi H; Li CY; Chen QC; Huang TB; Liu PC; Lou LM
    J BUON; 2015; 20(1):261-8. PubMed ID: 25778326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.
    He YQ; Zhu JH; Huang SY; Cui Z; He J; Jia WH
    Tumour Biol; 2014 Dec; 35(12):12509-17. PubMed ID: 25204673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.
    Li G; Li D
    Hum Immunol; 2016 May; 77(5):418-25. PubMed ID: 27006334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
    Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single Nucleotide Polymorphisms in
    Bradshaw G; Haupt LM; Aquino EM; Lea RA; Sutherland HG; Griffiths LR
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30818878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma.
    Worrillow L; Roman E; Adamson PJ; Kane E; Allan JM; Lightfoot TJ
    Cancer Epidemiol; 2009 Oct; 33(3-4):257-60. PubMed ID: 19736055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic polymorphisms in the DNA repair gene, XRCC1 associate with non-Hodgkin lymphoma susceptibility: A systematic review and meta-analysis.
    Li Y; Bai O; Cui J; Li W
    Eur J Med Genet; 2016 Feb; 59(2):91-103. PubMed ID: 26723520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study.
    Peckham-Gregory EC; Thapa DR; Martinson J; Duggal P; Penugonda S; Bream JH; Chang PY; Dandekar S; Chang SC; Detels R; Martínez-Maza O; Zhang ZF; Hussain SK
    Cancer Epidemiol; 2016 Dec; 45():47-57. PubMed ID: 27701053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of meningioma and common variation in genes related to innate immunity.
    Rajaraman P; Brenner AV; Neta G; Pfeiffer R; Wang SS; Yeager M; Thomas G; Fine HA; Linet MS; Rothman N; Chanock SJ; Inskip PD
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1356-61. PubMed ID: 20406964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.
    Reiner AP; Wurfel MM; Lange LA; Carlson CS; Nord AS; Carty CL; Rieder MJ; Desmarais C; Jenny NS; Iribarren C; Walston JD; Williams OD; Nickerson DA; Jarvik GP
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1407-12. PubMed ID: 18451331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.